Black Pepper Essential Oil
Natural health product licensed in Canada
- Other names
- Black Pepper
- Licence holder
- doTERRA Manufacturing, LLC.
- NPN or DIN-HM
- 80075353
- Status
- Active licence
- Licence date
- 31 January 2017
- Revision date
- Not provided
- Form
- Huile
- Route of administration
- Inhalation, Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Piper nigrum Source : Fruit | 100 Pour cent |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Huile ; maximum: 12 Huile | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Used in aromatherapy to help relieve joint/muscle pain associated with sprain/strain/rheumatoid arthritis, to help relieve headache, as a carminative/antispasmodic for symptomatic relief of digestive discomfort and to help relieve colds/cough.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For occasional use only. Keep out of reach of children. Not for oral use. Avoid contact with eyes and mucous membranes; if this happens, rinse thoroughly with vegetable oil. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. Consult a health care practitioner prior to use if you have epilepsy or asthma, or if symptoms persist or worsen. If you are pregnant or breastfeeding do not use this product. Avoid exposure of applied area(s) to the sun. If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
Source
Official Health Canada record, licence 80075353
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.